Atezolizumab and Nab-Paclitaxel in Advanced Triple-Negative Breast Cancer. Reply

Peter Schmid; Stephen Y. Chui; Leisha A. Emens

doi:10.1056/NEJMc1900150

Atezolizumab and Nab-Paclitaxel in Advanced Triple-Negative Breast Cancer. Reply

Peter Schmid, Stephen Y. Chui, Leisha A. Emens

Research output: Contribution to journal › Letter › peer-review

Original language	English (US)
Pages (from-to)	987-988
Number of pages	2
Journal	The New England journal of medicine
Volume	380
Issue number	10
DOIs	https://doi.org/10.1056/NEJMc1900150
State	Published - Mar 7 2019
Externally published	Yes

ASJC Scopus subject areas

Medicine(all)

Access to Document

10.1056/NEJMc1900150

Cite this

@article{25cdd5813af540d2aedfe6c865d06ad2,

title = "Atezolizumab and Nab-Paclitaxel in Advanced Triple-Negative Breast Cancer. Reply",

author = "Peter Schmid and Chui, {Stephen Y.} and Emens, {Leisha A.}",

year = "2019",

month = mar,

day = "7",

doi = "10.1056/NEJMc1900150",

language = "English (US)",

volume = "380",

pages = "987--988",

journal = "New England Journal of Medicine",

issn = "0028-4793",

publisher = "Massachussetts Medical Society",

number = "10",

}

TY - JOUR

T1 - Atezolizumab and Nab-Paclitaxel in Advanced Triple-Negative Breast Cancer. Reply

AU - Schmid, Peter

AU - Chui, Stephen Y.

AU - Emens, Leisha A.

PY - 2019/3/7

Y1 - 2019/3/7

UR - http://www.scopus.com/inward/record.url?scp=85062894083&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85062894083&partnerID=8YFLogxK

U2 - 10.1056/NEJMc1900150

DO - 10.1056/NEJMc1900150

M3 - Letter

C2 - 30855757

AN - SCOPUS:85062894083

SN - 0028-4793

VL - 380

SP - 987

EP - 988

JO - New England Journal of Medicine

JF - New England Journal of Medicine

IS - 10

ER -

Atezolizumab and Nab-Paclitaxel in Advanced Triple-Negative Breast Cancer. Reply

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this